???pagination.result.count???
???pagination.result.page???
1
The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors. , Hoestgaard-Jensen K., Br J Pharmacol. October 1, 2013; 170 (4): 919-32.
Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse. , Hondebrink L., Neurotoxicology. December 1, 2011; 32 (6): 823-7.
About a snail, a toad, and rodents: animal models for adaptation research. , Roubos EW ., Front Endocrinol (Lausanne). January 1, 2010; 1 4.
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite. , Berezhnoy D., BMC Pharmacol. June 13, 2008; 8 11.
Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. , Serantes R., J Biol Chem. May 26, 2006; 281 (21): 14632-43.
Modulation of GABAA receptor function by G protein-coupled 5-HT2C receptors. , Huidobro-Toro JP., Neuropharmacology. January 1, 1996; 35 (9-10): 1355-63.
Platelet-derived growth factor receptor is a novel modulator of type A gamma-aminobutyric acid-gated ion channels. , Valenzuela CF., Mol Pharmacol. December 1, 1995; 48 (6): 1099-107.
Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. , Ebert B., Mol Pharmacol. November 1, 1994; 46 (5): 957-63.